Navigation Links
Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
Date:4/14/2009

Commercial Managed Care - Managed care plans come in many varieties and serve different purposes. This course looks at the characteristics of the different types of managed care organizations (MCOs), the different types of benefit and formulary design, the various mechanisms that plans use to manage drug utilization and costs, the impact of patent expiration and generic utilization on branded products, tactics health plans use to drive generic utilization, and potential future trends in managed care.
  • Medicare - With the launch of the Medicare Part D drug benefit, Medicare's impact on pharmaceutical and biologic product sales has dramatically increased. This course provides team members with the necessary background to understand and effectively sell to this segment of the market, including the four key components of Medicare: Parts A, B, C, & D, the characteristics of the Medicare population, the current structure and potential changes to the Part D drug benefit, and the common questions about the Medicare program.
  • Medicaid - The role and importance of Medicaid has been transformed by the Medicare Part D drug benefit. This course helps team members understand how this program has evolved and how it is managed. Topics covered in this course include, understanding the characteristics of the Medicaid population, changes to Medicaid as a result of Medicare Part D, the role of preferred drugs lists in Medicaid utilization management, and the priorities and challenges for the government in managing and paying for drugs.
  • Specialty Pharmacy - Specialty products are under increasing financial pressure in the current reimbursement environment. This course helps team members understand the management structure and economics of a physician practice that utilizes specialty products, including the day-to-day roles and responsibilities of practice managers, as well as their key challenges, the
    '/>"/>

  • SOURCE Pharmaceutical Institute
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
    2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
    3. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
    4. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
    5. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
    6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
    7. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
    8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
    9. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
    10. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
    11. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... NEW YORK , Dec. 23, 2014  NeuroLifeSciences ... of mazindol in children with attention deficit/hyperactivity disorder published ... 2014 . The paper, titled "Pilot ... deficit/hyperactivity disorder" ( Konofal et al, Drug ... 2014 ) shows that mazindol might be an ...
    (Date:12/22/2014)... 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, with ... announced positive topline safety and tolerability results ... SYN-004, the Company,s investigational oral beta-lactamase enzyme ... (C. difficile) infection, antibiotic-associated diarrhea and ...
    (Date:12/22/2014)... 2014  Alternative Energy & Environmental Solutions, Inc., ... a letter of intent to acquire BioTechPharma Corporation, ... a nanotechnology-based development platform used to create drug ... on-site collection and testing to identify infectious disease, ... an immediate, non-invasive and cost-effective manner. ...
    (Date:12/22/2014)... Calif. , Dec. 22, 2014  ( www.competitivehealth.com ... CoPatient, an online medical bill review and advocacy service, ... in the FREE WellCard Savings discount health services marketplace. ... bill that was more than they expected to pay. ... reduce health care costs, WellCard Savings is pleased to ...
    Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2
    ... the stress of the Second Lebanon War suffered fewer attacks ... focusing on feelings. This has been shown in a new ... the Technion-Israel Institute of Technology and Carmel Medical Center. "Because ... is important to uncover all the factors that impact the ...
    ... school in Grenoble, France, and Virginia Tech is using ... students, work will help gene synthesis companies and their ... as harmful agents for bioterrorism. Synthetic biology offers ... agriculture, and other areas. For a few thousand dollars, ...
    ... 6 Novavax, Inc. (Nasdaq: ... , Ph.D. to its board of directors.  Dr. Douglas is ... a leader of Genzyme,s Corporate Development team, Dr. Douglas has ... alliances as well as Genzyme,s venture investments.  He has served ...
    Cached Biology Technology:Can multiple sclerosis attacks be minimized in a war zone? 2iGEM team helps prevent rogue use of synthetic biology 2NOVAVAX Elects Richard H. Douglas to its Board of Directors 2NOVAVAX Elects Richard H. Douglas to its Board of Directors 3
    (Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday ... biometrics industry as Acuity Market Intelligence reports that ... finally be open. Acuity forecasts that intensifying demand ... that incorporate biometrics will drive a global market ... biometric devices by 2020.   According ...
    (Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/s6qzt5/samsung_galaxy_s5 ) ... Galaxy S5 - Home Button Synaptics Fingerprint Sensor ... http://photos.prnewswire.com/prnh/20130307/600769 ... the iPhone 5S, Samsung introduces for the first ... The Galaxy S5 home button presents an ...
    (Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
    Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
    ... - Bacteria possess an ingenious mechanism for preventing oxygen from ... new finding of a team of biologists that includes Joris ... Belgium, connected to the Vrije Universiteit Brussel. The scientists made ... Escherichia coli . By means of this model organism, ...
    ... CHAMPAIGN, Ill. In a new study, researchers report ... have a helpful, or harmful, effect on the heart, ... appears in the journal Circulation Research , found ... on the heart muscle offer the most benefit to ...
    ... in many countries of the world. It is widely ... It also is considered an exemplar plant species for ... of the research presented in this special collection used ... probe some of the most intriguing questions in genetics ...
    Cached Biology News:Biologists discover bacterial defense mechanism against aggressive oxygen 2Carvedilol shown to have unique characteristics among beta blockers 2PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4
    ...
    Immunogen: Synthetic peptide: R(89) L A F T V D D N P T K P T T R Q R Y(107) Storage: -20 C, Avoid Freeze/Thaw Cycles...
    ...
    Liquid. Phycoerythrin conjugate is in PBS, pH 7.4 containing 1% BSA and 0.1% sodium azide....
    Biology Products: